⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27823842 | 0.97 | — | — | |
| SCHEMBL28257554 | 0.82 | — | — | |
| SCHEMBL27331102 | 0.72 | — | — | |
| SCHEMBL6014661 | 0.67 | — | — | |
| SCHEMBL18571420 | 0.67 | — | — | |
| SCHEMBL24815935 | 0.67 | — | — | |
| SCHEMBL4699012 | 0.67 | — | — | |
| SCHEMBL28328097 | 0.67 | — | — | |
| SCHEMBL29655947 | 0.67 | — | — | |
| SCHEMBL8585013 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023081306-A1 | INDOLIZINE COMPOUNDS FOR THE TREATMENT OF MENTAL DISORDERS OR MENTAL ENHANCEMENT | TACTOGEN INC (US) | 2023-05-11 | — | — | WO | disclosed |